Dangerous Behavior: Clinical Trials

6 trials for Dangerous Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown, 1 withdrawn. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 4, Unknown 1, Withdrawn 1
Phase 22Completed 1, Withdrawn 1

Follow Dangerous Behavior: new trials by email Literature Review of Dangerous Behavior trials Research Report on Dangerous Behavior

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests
Cannabis, Alcohol - Driving Impaired, Alcohol Intoxication
Phase 1 / Phase 2WithdrawnUniversity of California, San Diego2022-08-012023-09-07
Detection of Cannabis Impairment With ISBRG's SpotLight-THC
Cannabis(THC) inhaled - Cannabis
Phase 1UnknownISBRG Corp752022-03-012022-03-11
Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim
Placebo (Lactose) Capsule, 0.75 mg Alprazolam Capsule, Cannabis (6.18% THC / <0.025% CBD) - Driving Behavior, Driving Under the Influence
Phase 1CompletedTimothy L. Brown132021-07-162023-07-25
The Impact and Detection of Driving Impairments Associated With Acute Cannabis Smoking
Cannabis - Cannabis Intoxication
Phase 1 / Phase 2CompletedUniversity of California, San Diego1992017-02-242022-01-04
Interaction of Alcohol With Energy Drinks
Alcohol and energy drink, Alcohol, Energy drink - Alcohol-Related Disorders, Drinking and Driving
Phase 1CompletedParc de Salut Mar162016-06-012016-10-19
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
Active Ethanol, Active Iomazenil, Placebo - Active Ethanol and Active Iomazenil, Active Ethanol and Placebo Iomazenil
Phase 1CompletedVA Office of Research and Development332012-12-142024-10-09

Narrower conditions

Driving Under the Influence (6)  ·  Marijuana Abuse (4)  ·  Alcohol-Related Disorders (1)  ·  Alcoholic Intoxication (1)  ·  Memory Disorders (1)  ·  Substance-Related Disorders (1)

Broader conditions

Behavior (6)  ·  Criminal Behavior (6)  ·  Chemically-Induced Disorders (5)  ·  Mental Disorders (5)  ·  Substance-Related Disorders (4)  ·  Alcohol-Related Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

nabiximols (3)  ·  Ethanol (2)  ·  Alprazolam (1)  ·  Capsules (1)  ·  Dronabinol (1)  ·  Energy Drinks (1)  ·  Inhalation (1)  ·  Lactose (1)

Sponsors

University of California, San Diego (2)  ·  ISBRG Corp (1)  ·  Parc de Salut Mar (1)  ·  Timothy L. Brown (1)  ·  VA Office of Research and Development (1)

Countries

United States (4)  ·  Spain (1)

Top investigators

Deepak C D'Souza, MD MBBS (1)  ·  Thomas D Marcotte, PhD (1)  ·  Timothy L Brown (1)  ·  Timothy L Brown, Ph.D. (1)

Results publications

PMID 31527291, PMID 34173005, PMID 15094417, PMID 17063973, PMID 17916224, PMID 21049267, PMID 26144593, PMID 26257143, PMID 30615854, PMID 34185831, PMID 34338762, PMID 35080588, PMID 37531115